the state is weaker and prisons are notorious for escapes. Victory here would be more akin to winning a civil war. Mr Bukele may end up doing some good in Haiti, especially if he persuades others to send more peacekeepers. But he needs to make clear whether his soldiers will work with the UN or do their own thing. The UN could help with vetting and training, and discourage abuses against civilians. Yet Mr Bukele may prefer his own gloves-off approach. His opacity is troubling. He should spell out his intentions—and remember that it is easier to start a fight than to end one. ■ This article was downloaded by zlibrary from https://www.economist.com/leaders/2026/11/05/el-salvadors-gangbuster-tries-his- luck-in-haiti
The world must act to stop a cyber-disaster Governments should make sure defenders have better models than attackers do Nov 5th 2026 It was meant to be “cyber-security awareness month”. Experts now call it “Black October”. In recent weeks the normal flow of computer hacks and bugs that engineers must constantly stem has become a torrent. The cause is artificial intelligence, which has turbocharged cyber malfeasance. Open- source AI models have empowered attackers to work with inhuman efficiency, competence and persistence. As a result, years’ worth of critical flaws have been exposed in days. Those flaws range from shocking to ridiculous. Engineers have rushed to fix a flaw in PHP, a widely used programming language, that let attackers take over any computer using it. Freezers in supermarkets across Europe powered down on the instructions of cyber-criminals. And a crucial internet security
certificate was revealed to have a private key of “4”, when it should have been a hundred digits long. Nobody knows what bugs might have been found and exploited in private. These events have been sobering for the many commentators, including this newspaper, who hoped that the disruption to cyber-security from ai would be short-lived, and that the technology itself would help those who defend digital systems more than it would empower crooks. Those hopes are being dashed. Instead, the digital infrastructure on which modern life depends looks increasingly vulnerable to ai. Urgent action is needed to defend it. Why are defenders struggling? The first reason is that many of them do not have the most advanced tools. In April Anthropic, a leading model-maker, launched “Project Glasswing”, an invitation-only club with access to the full cyber capabilities of its frontier models. It originally intended to broaden the membership widely. A similar programme from OpenAI was launched with a promise to democratise access to its tools. However, access to powerful AI has become a geopolitical issue. Both of the model-makers now need sign-off from America’s federal government before admitting new members to their clubs, so expanding them has become a painful political process. In the meantime those outside the gates must defend themselves with the same open-source tools that are powering the attacks. Some are stuck in a no-man’s land: unable to access American tech, but also scared of using Chinese alternatives. The second problem is that when AI is used benignly it creates a friendly- fire problem. The moment that a “patch” for a newly identified vulnerability is released, hackers’ AI models can examine it. This may reveal exactly what the weakness was and how to exploit it in systems that have not yet been fixed. If defenders are really unlucky—as they were with php—the patch may leak before it is released for defenders to use to fix their code. Attackers can then operate against still-defenceless systems. A final issue is that attackers can exploit prosaic vulnerabilities faster and on a greater scale (see Business section). Cyber-security is not just about having strong systems available in theory, but avoiding laxity in practice. Unfortunately, AI has made human carelessness easier to exploit without
making computer users any wiser. An internet-connected fridge running outdated software or using a default password has been a security hazard for decades. Only now, however, have attackers found it so easy to automate the search for and exploitation of weak points, running thousands of attacks in parallel. Companies and governments must act decisively against these threats. Generating an imbalance in cyber-weaponry is crucial. With equal firepower, defenders rely on a narrow natural advantage: they must find and patch only single vulnerabilities—isolated problems which might in theory help create a breach. Attackers typically need to know of a whole chain of those vulnerabilities in order to breach a system. Now that AI-powered attacks are proliferating, this advantage is too narrow. Defenders need a bigger armoury. America’s government should take a more permissive attitude to membership of cyber-defence programmes, or at least approve new joiners faster. It would also be better if attackers’ capabilities were pushed further behind the frontier. China’s government has recognised the folly of distributing potent cyber-weapons to all, and is requiring labs to limit the destructive potential of newly released systems. Organisations that are not yet using AI constantly to find and close security holes have fallen behind the curve and must catch up. Some entities need more help. In America efforts like Texas’s “Project Watershed 250” are funnelling resources to providers of infrastructure to help with the basics. Those efforts should be expanded. In time, the software industry may be able to verify some code formally, thereby proving that it is unhackable, much as a mathematician proves a theorem. Commerce, infrastructure and human relationships have come to rely on the assumption that the internet is secure. A sudden loss of cyber-security would therefore pose a grave threat to society. Cyber-security awareness has risen over the past month. Action must follow. ■ This article was downloaded by zlibrary from https://www.economist.com/leaders/2026/11/05/the-world-must-act-to-stop-a-cyber- disaster
Patients are acting more like consumers. Good Health care cannot be an ordinary market. But it could be much more like one Nov 5th 2026 The person who uses a product usually chooses it and pays for it. The great exception is health care. Most of the time insurers (public or private) decide what is covered; doctors decide what is prescribed and patients take what they are given. The result is markets riddled with inefficiency, and nowhere more so than in America, the world’s biggest. This year Americans are expected to spend about $6trn on health, nearly a fifth of their country’s GDP. Yet for all that money, about one adult in ten could not get an appointment when they needed one last year, and more than a quarter put off or skipped care because of the cost. No wonder patients are taking matters into their own hands. They pepper chatbots with questions such as how to decode a blood test or prepare for an
appointment; every week more than 300m people ask ChatGPT about health, says OpenAI, its creator. The market for tests that patients order themselves has grown to be worth about $4bn a year in America, double its size in 2021, reckons Morgan Stanley, a bank. And drugmakers have started selling directly to patients. Eli Lilly, an American pharmaceutical giant, now fills about half of new prescriptions for its obesity jab in America this way, bypassing insurers. All three developments are good news. One reason is that patient-led markets bring lower prices. Take drugs. In America their true cost is obscured by a tangle of middlemen and insurers, who negotiate secret discounts from inflated list prices. When patients pay directly, prices are transparent and drugmakers must compete. New obesity drugs are a good example. Novo, a Danish drugmaker, launched Wegovy in 2021 at a list price of about $1,350 a month. That led to a price war with Lilly, and competition from cheap copies. Both firms now sell their jabs direct to patients for as little as $300-350 a month. The same logic works for older products. Mark Cuban Cost Plus Drug Company, an online pharmacy founded by a billionaire, buys generics from their makers and sells them at cost plus a 15% mark-up. One study found that patients with employer- provided insurance who pay over $15 for a prescription could buy it more cheaply from Cost Plus nearly 80% of the time. When patients pay, firms also come up with new ways to sell to them. “Direct primary care”, where medical practices ditch insurers and charge patients a monthly fee instead, has grown by nearly a fifth per year since 2022, to more than 3,600 practices in America. Others, such as Amazon’s One Medical, treat common ailments on a pay-per-visit basis. Drugmakers are looking at treatments that consumers will pay for, even if insurers will not. Novo is eyeing treatments for hair loss, addiction and menopause, conditions that big pharma long dismissed as unworthy of serious research. Even fighting off ageing now attracts money. Most profound of all is the erosion of the original source of market power: a doctor’s hold on medical knowledge. In 1963 Kenneth Arrow, an economist, said that health care could not work like an ordinary market partly because the information a doctor possesses is “necessarily very much greater than that of the patient, or at least so it is believed by both parties”. Technology has since narrowed that gap. Chatbots, though hardly infallible, translate
medical jargon into plain English and set out the treatment options for a condition. Increasingly they work with patients’ own data, too. Consumer-led health care carries dangers. The first is quackery. Websites and influencers peddle peptides and supplements that promise bigger muscles, better skin or a longer life. Many do nothing and some do harm. Regulators should make sure sellers do not lie about their products. Access matters, too. Nearly all consumer health care is paid for out of pocket, so for now it mostly serves the well-off. However, most innovations start out as luxuries and get cheaper. No one will shop for doctors from the back of an ambulance. Complex and emergency care will stay with doctors, hospitals and insurers. But in the routine parts of medicine, patients can and should be treated as customers. A bloated, paternalistic industry has kept them waiting long enough. ■ This article was downloaded by zlibrary from https://www.economist.com/leaders/2026/11/05/patients-are-acting-more-like- consumers-good